Repligen makes bioprocessing equipment and consumables used to manufacture biological drugs. It last closed at $163.81 on Nov 20, down 3.81% on the day. The next earnings report for RGEN is expected around Tue, Feb 23, 2027. For the quarter ended Sep 2026, RGEN reported EPS of -$0.68 on revenue of $209.3M, with revenue up 10.9% from a year ago. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months RGEN insiders bought $0 of stock on the open market and sold $7.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is RGEN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RGEN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RGENStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RGEN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 6% below its 20 day and 8% below its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the swing low (Sep 10) at $161.14, and the nearest resistance the Pivot at $165.30.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 5.1%/day
Key levels
$198.8752 week high+21.4%
$185.03Swing high (Oct 22)+13.0%
$177.1650 day average+8.1%
$173.4620 day average+5.9%
$168.13Pivot R1+2.6%
$167.44100 day average+2.2%
$165.30Pivot+0.9%
$163.81Last close
$161.14Swing low (Sep 10)−1.6%
$160.98Pivot S1−1.7%
$145.74200 day average−11.0%
$100.9952 week low−38.3%
Indicators
RSI (14)
42.71
Middle of its range
Neutral
MACD
-3.02
Below its signal line
Bearish
Stochastic
30.6
Middle of its range
Neutral
ADX (14)
11.0
No clear trend
Williams %R
-87.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.6%
Change over 10 sessions
Bearish
ATR (14)
$8.35
Typical daily range, 5.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Turning up
Short trendBullish
Long trendNeutral
MomentumFading
StretchNormal
VolatilityNormal, 10.9%/day
Key levels
$198.8752 week high+21.4%
$185.03Swing high (Oct 22)+13.0%
$177.1650 day average+8.1%
$173.4620 day average+5.9%
$168.13Pivot R1+2.6%
$167.44100 day average+2.2%
$165.30Pivot+0.9%
$163.81Last close
$161.14Swing low (Sep 10)−1.6%
$160.98Pivot S1−1.7%
$145.74200 day average−11.0%
$100.9952 week low−38.3%
Indicators
RSI (14)
51.55
Middle of its range
Neutral
MACD
8.36
Below its signal line
Bearish
Stochastic
32.3
Middle of its range
Neutral
ADX (14)
18.5
No clear trend
Williams %R
-84.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
0.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.8%
Change over 10 sessions
Bearish
ATR (14)
$17.89
Typical daily range, 10.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for RGEN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RGEN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RGEN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RGENHow many large options trades hit RGEN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RGEN in the last 90 days.
From SEC Form 4 filings by RGEN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RGEN is in one of them and how their past RGEN trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Repligen
Repligen is a life sciences company based in Waltham, Massachusetts, that makes equipment and consumables used to manufacture biological drugs. Its product lines cover filtration, chromatography, process analytics and proteins, including filters, tangential flow systems, columns that come already packed with resin, and fluid management parts. Its main customers are drug developers, contract manufacturers and other life science companies that make antibody-based drugs, vaccines, and cell and gene therapies.